From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.
Discover expert strategies for selecting optimal labels for single particle tracking in super-resolution microscopy ...
Estrella Immunopharma, Inc. ("Estrella" or the "Company"), a clinical stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS® T-cell therapies to treat cancer and autoimmune ...
Progression free survival (PFS) of 74% at 16 months compares favourably to standard of care PFS of 50% at 11.5 months 1 Strong PFS consistent across key subgroups Reaffirms selection of iSCIB1+ and ...
Today, NeuroVice announced that PATI is now commercially available, marking a breakthrough moment for millions of patients living with focal and grand-mal seizures. The company will debut the ...
At an apple processing facility in Watsonville, the 2025 UC Santa Cruz iGEM team took a deep dive into mycotoxins in food, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results